From: The epidemiology and etiology of adhesive capsulitis in the U.S. Medicare population
 | All Adhesive Capsulitis Cases (N = 92,437) |
---|---|
N (%) | |
Male | 33,012 (35.7) |
Race | |
 Asian | 2,628 (2.8) |
 Black | 6,199 (6.7) |
 Hispanic | 1,620 (1.8) |
 Other | 2,186 (2.4) |
 White | 79,804 (86.3) |
Dual eligible for Medicaida | 10,999 (11.9) |
Mean Age (Standard Deviation) | 75.7 (7.0) |
Age Group | |
 66–69 | 24,026 (26.0) |
 70–75 | 29,143 (31.5) |
 76–79 | 14,380 (15.6) |
 80–85 | 15,628 (16.9) |
 86 +  | 9,260 (10.0) |
Region | |
 Midwest | 18,758 (20.3) |
 Northeast | 19,310 (20.9) |
 South | 37,440 (40.5) |
 West | 16,334 (17.7) |
Charlson Comorbidity Index (CCI) | |
 0 | 24,775 (26.8) |
 1 | 20,391 (22.1) |
 2 | 14,683 (15.9) |
 3 | 11,426 (12.4) |
 4 +  | 21,162 (22.9) |
Frailty Risk Index (FRI) | |
 0 | 34,721 (37.6) |
 1 | 30,776 (33.3) |
 2 | 13,593 (14.7) |
 3 +  | 13,347 (14.4) |
Mean Previous Year Medicare Spending (SD)b | $14,176 (23,287) |
Comorbidities | |
 Diabetes, Type 1 | 3,220 (3.5) |
 Diabetes, Type 2 | 28,611 (31.0) |
 Hyperlipidemia | 41,106 (44.5) |
 Hypertension | 53,979 (58.4) |
 Thyroid Disorder | 16,364 (17.7) |
 Rheumatoid arthritis | 3,883 (4.2) |
 Gout | 2,744 (3.0) |
 Parkinson’s Disease | 1,299 (1.4) |